Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386326464> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4386326464 abstract "Patients with “penta-refractory” multiple myeloma (MM) are challenging to treat given the limited treatment options available to them. Belantamab mafodotin is the first B-cell maturation antigen (BCMA)-targeting antibody-drug conjugate approved for the treatment of relapsed/refractory MM (RRMM). In this case report, we reviewed in detail three female patients who were diagnosed with MM international scoring system (ISS)-3 and were heavily pretreated, and refractory to CD38 monoclonal antibodies, two proteasome inhibitors, and two immunomodulatory agents. These patients were started on belantamab mafodotin and experienced rapid and explosive clinical, biochemical, and extramedullary disease progression within a short period of time. All three patients experienced worsening cytopenia, increased transfusion requirement, severe uncontrolled bony pain, recurrent infections, and frequent hospital admissions. Two of them passed away due to disease progression complications within a few months of starting belantamab mafodotin. Although belantamab mafodotin as a single agent was withdrawn from the market after the DREAMM-3 trial failed to achieve its primary endpoint in late RRMM, BCMA-targeted therapy may still be a promising treatment approach, and the role of belantamab mafodotin is yet to be revealed in combination therapy in early RRMM." @default.
- W4386326464 created "2023-09-01" @default.
- W4386326464 creator A5020795985 @default.
- W4386326464 creator A5056497882 @default.
- W4386326464 creator A5073815451 @default.
- W4386326464 creator A5078320719 @default.
- W4386326464 creator A5092132119 @default.
- W4386326464 date "2023-08-31" @default.
- W4386326464 modified "2023-10-05" @default.
- W4386326464 title "Explosive Disease Progression After Single-Agent B-cell Maturation Antigen-Targeted Treatment in Multiple Myeloma: A Report of Three Cases in Sheikh Shakhbout Medical City" @default.
- W4386326464 cites W1977691688 @default.
- W4386326464 cites W2144728882 @default.
- W4386326464 cites W2549893547 @default.
- W4386326464 cites W2921533600 @default.
- W4386326464 cites W2948728876 @default.
- W4386326464 cites W2984517150 @default.
- W4386326464 cites W2995934717 @default.
- W4386326464 cites W3031617373 @default.
- W4386326464 cites W3043410628 @default.
- W4386326464 cites W3048382072 @default.
- W4386326464 cites W3095662656 @default.
- W4386326464 cites W3096378490 @default.
- W4386326464 cites W3166269067 @default.
- W4386326464 cites W3215957819 @default.
- W4386326464 cites W4200179980 @default.
- W4386326464 cites W4306912324 @default.
- W4386326464 cites W4312065937 @default.
- W4386326464 cites W4323848852 @default.
- W4386326464 doi "https://doi.org/10.7759/cureus.44433" @default.
- W4386326464 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37791224" @default.
- W4386326464 hasPublicationYear "2023" @default.
- W4386326464 type Work @default.
- W4386326464 citedByCount "0" @default.
- W4386326464 crossrefType "journal-article" @default.
- W4386326464 hasAuthorship W4386326464A5020795985 @default.
- W4386326464 hasAuthorship W4386326464A5056497882 @default.
- W4386326464 hasAuthorship W4386326464A5073815451 @default.
- W4386326464 hasAuthorship W4386326464A5078320719 @default.
- W4386326464 hasAuthorship W4386326464A5092132119 @default.
- W4386326464 hasBestOaLocation W43863264641 @default.
- W4386326464 hasConcept C121332964 @default.
- W4386326464 hasConcept C126322002 @default.
- W4386326464 hasConcept C141071460 @default.
- W4386326464 hasConcept C142424586 @default.
- W4386326464 hasConcept C143998085 @default.
- W4386326464 hasConcept C203092338 @default.
- W4386326464 hasConcept C2776364478 @default.
- W4386326464 hasConcept C2777478702 @default.
- W4386326464 hasConcept C2780007613 @default.
- W4386326464 hasConcept C2780366003 @default.
- W4386326464 hasConcept C535046627 @default.
- W4386326464 hasConcept C71924100 @default.
- W4386326464 hasConcept C87355193 @default.
- W4386326464 hasConceptScore W4386326464C121332964 @default.
- W4386326464 hasConceptScore W4386326464C126322002 @default.
- W4386326464 hasConceptScore W4386326464C141071460 @default.
- W4386326464 hasConceptScore W4386326464C142424586 @default.
- W4386326464 hasConceptScore W4386326464C143998085 @default.
- W4386326464 hasConceptScore W4386326464C203092338 @default.
- W4386326464 hasConceptScore W4386326464C2776364478 @default.
- W4386326464 hasConceptScore W4386326464C2777478702 @default.
- W4386326464 hasConceptScore W4386326464C2780007613 @default.
- W4386326464 hasConceptScore W4386326464C2780366003 @default.
- W4386326464 hasConceptScore W4386326464C535046627 @default.
- W4386326464 hasConceptScore W4386326464C71924100 @default.
- W4386326464 hasConceptScore W4386326464C87355193 @default.
- W4386326464 hasLocation W43863264641 @default.
- W4386326464 hasLocation W43863264642 @default.
- W4386326464 hasOpenAccess W4386326464 @default.
- W4386326464 hasPrimaryLocation W43863264641 @default.
- W4386326464 hasRelatedWork W1989734946 @default.
- W4386326464 hasRelatedWork W2059110826 @default.
- W4386326464 hasRelatedWork W2102372291 @default.
- W4386326464 hasRelatedWork W2111732928 @default.
- W4386326464 hasRelatedWork W2275646114 @default.
- W4386326464 hasRelatedWork W230412469 @default.
- W4386326464 hasRelatedWork W2379244710 @default.
- W4386326464 hasRelatedWork W2531713994 @default.
- W4386326464 hasRelatedWork W3030219566 @default.
- W4386326464 hasRelatedWork W3031374739 @default.
- W4386326464 isParatext "false" @default.
- W4386326464 isRetracted "false" @default.
- W4386326464 workType "article" @default.